Although the Supreme Court has recently increased its review of patent laws, the rulings have only eliminated deviations and reinforced precedent. However, the implications for nutraceutical companies is that their patent applications would have to represent a true invention and be very precise, rather than being a collection of scientific facts or trivial improvements. In his byline on www.nutraingredients-usa.com, Foley’s John Garvey discusses three recent cases reviewed by the Supreme Court and the impact of these decisions on dietary supplement and functional foods companies looking to patent their technologies.
Related Insights
17 April 2025
Manufacturing Industry Advisor
Foley Automotive Update and the Latest Insights on Tariffs
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.
17 April 2025
Foley Viewpoints
Delaware Law on Fiduciary Duties and Stockholder Agreements
Delaware corporate law is renowned for its balance between flexibility in business arrangements and the fundamental principles of fiduciary accountability.
17 April 2025
Preparing for a “Common-Sense” FAR: What Federal Contractors Need to Know About the Trump Administration’s Plans to Streamline the Federal Acquisition Regulation
In a new Executive Order issued on April 15, 2025 titled, “Restoring Common Sense to Federal Procurement,” President Trump has directed his Administration to make major revisions to the Federal Acquisition Regulation—the voluminous set of rules governing the U.S. Government’s acquisition of products and services—with the stated purpose of making the federal procurement process more “agile, effective, and efficient.”